Metastatic Gastric Adenocarcinoma Unknown Status Phase 2 Trials for Rivoceranib (DB14765)

Also known as: Adenocarcinoma gastric / Adenocarcinoma of stomach (disorder)

IndicationStatusPhase
DBCOND0074521 (Metastatic Gastric Adenocarcinoma)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03116555Apatinib Plus Irinotecan as Second-line Treatment in AGC or EGJATreatment